A new mechanism for primary resistance to gefitinib in lung adenocarcinoma : The role of a novel G796A mutation in exon 20 of EGFR

A new mechanism for primary resistance to gefitinib in lung adenocarcinoma : The role of a novel G796A mutation in exon 20 of EGFR
复制标题

肺腺癌吉非替尼原发耐药的新机制:EGFR外显子20中新型G796A突变的作用

DOI:
--
复制
发表时间:
2007
期刊:
Anticancer Res (in press)
影响因子:
--
通讯作者:
Uramoto H
Uramoto H
中科院分区:
--
文献类型:
--
作者:
斉藤真一;山中潤一;他;Oyama T;Sugaya M;Oyama T;Uramoto H

文献摘要

相似文献